The GLP is committed to full transparency. Download and review our just-released 2019 Annual Report.

Despite judge’s finding of ‘weak’ evidence glyphosate causes cancer, Monsanto could face Roundup litigation onslaught

| July 12, 2018

Hundreds of lawsuits alleging Roundup weed killer caused cancer cleared a big hurdle [July 10] when a U.S. judge ruled that cancer victims and their families could present expert testimony linking the herbicide to non-Hodgkin’s lymphoma.

U.S. District Judge Vince Chhabria said evidence that the active ingredient in Roundup — glyphosate — can cause the disease seemed “rather weak.” Still, the opinions of three experts linking glyphosate and non-Hodgkin’s lymphoma were not “junk science” that should be excluded from a trial, the judge ruled.

Many government regulators have rejected a link between cancer and glyphosate. Monsanto has vehemently denied such a connection, saying hundreds of studies have established that the chemical is safe.

Related article:  Fourth-generation Australian farmer: GM, chemicals and organic methods needed for sustained food security

The company is facing hundreds of lawsuits in state and federal courts that claim otherwise. Chhabria is presiding over more than 400 of them.

The lawsuits say agrochemical giant Monsanto, which makes Roundup, long knew about the cancer risk but failed to warn people. The ruling allows the claims to move forward, though the judge warned it could be a “daunting challenge” to convince him to allow a jury to hear testimony that glyphosate was responsible for individual cancer diagnoses.

Read full, original article: Lawsuits alleging Roundup caused cancer can move forward

 

The GLP aggregated and excerpted this article to reflect the diversity of news, opinion, and analysis. Click the link above to read the full, original article.
News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.

Send this to a friend